Osteosarcoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Vaccine to treat osteosarcoma in dogs receives conditional license - American Veterinary Medical Association



Vaccine to treat osteosarcoma in dogs receives conditional license 
American Veterinary Medical Association
20, 2017, that the Department of Agriculture's Center for Veterinary Biologics has granted a conditional license to Aratana for its vaccine intended to treat dogs with osteosarcoma. The immunotherapeutic vaccine was developed by Aratana with a Listeria ...

 


Aratana receives conditional approval for canine osteosarcoma vaccine - dvm360



dvm360
 
Aratana receives conditional approval for canine osteosarcoma vaccine 
dvm360
Aratana Therapeutics has been granted conditional approval for its canine osteosarcoma vaccine, live Listeria vector (AT-014) by the USDA's Center for Veterinary Biologics, according to a release from the company. It has been approved for treatment of ...

 


Bone Cancer Vaccine for Dogs Receives Conditional License - PrecisionVaccinations (press release)



Bone Cancer Vaccine for Dogs Receives Conditional License 
PrecisionVaccinations (press release)
January 18th, 2018 ? The USDA Center for Veterinary Biologics has granted a conditional license to Aratana for its vaccine intended to treat dogs with osteosarcoma. This study led by Dr. Nicola J. Mason, an associate professor of medicine at the ...

 


USDA Grants Canine Osteosarcoma Vaccine With Conditional License - American Veterinarian



American Veterinarian
 
USDA Grants Canine Osteosarcoma Vaccine With Conditional License 
American Veterinarian
USDA Grants Canine Osteosarcoma Vaccine With Conditional License. A new canine osteosarcoma vaccine has been granted a conditional license and will be tested among 2 dozen veterinary oncology groups. With enough success, the vaccine could be given a ...

 


Molecular imaging technique identifies lung nodules for resection in osteosarcoma patient - EurekAlert (press release)



Molecular imaging technique identifies lung nodules for resection in osteosarcoma patient 
EurekAlert (press release)
The case study "Utilization of targeted near-infrared molecular imaging to improve pulmonary metastasectomy of osteosarcomas," by Jarrod Predina, Andrew Newton, Charuhas Deshpande, and Sunil Singhal of The Perelman School of Medicine at the University ...

and more » 


Gabi Shull to perform at Colorado Springs benefit for Zach Sobiech Osteosarcoma Fund - Colorado Springs Gazette



Gabi Shull to perform at Colorado Springs benefit for Zach Sobiech Osteosarcoma Fund 
Colorado Springs Gazette
Gabi Shull, a 16-year-old from Warrensburg, Mo., is quiet but mighty, a petite fighter who didn't let cancer thwart her passion for dance. She'll come to Colorado for "Clouds," a company showcase by Synergy Dance Academy, and perform alongside two of ...

 


Aratana Therapeutics secures USDA conditional license for canine osteosarcoma vaccine - VeterinaryPracticeNews.com



VeterinaryPracticeNews.com
 
Aratana Therapeutics secures USDA conditional license for canine osteosarcoma vaccine 
VeterinaryPracticeNews.com
?Osteosarcoma is the most common primary bone tumor in dogs and, since there haven't been advances to raise the standard of care in nearly 20 years, dogs often face a poor prognosis,? said Ernst Heinen, DVM, Ph.D., chief development officer of Aratana ...

 


World Osteosarcoma Industry is Projected to Reach at a CAGR over ~8.7% by 2023 - Industry Today (press release)



World Osteosarcoma Industry is Projected to Reach at a CAGR over ~8.7% by 2023 
Industry Today (press release)
Currently, treatment methods, for instance, chemotherapy is directed within prospective clinical trials. Total duration for osteosarcoma is about 6-12 months. In drug treatment, doxorubicin is first and most commonly used drug for patients. Cisplatin ...

 


Near-infrared molecular imaging identifies lung nodules for resection in osteosarcoma - Drug Target Review



Drug Target Review
 
Near-infrared molecular imaging identifies lung nodules for resection in osteosarcoma 
Drug Target Review
In a proof-of-principle case report, researchers announce that targeted fluorescence successfully identified pulmonary metastases in a patient with osteosarcoma, making it easier for surgeons to locate the tumours for resection. Osteosarcomas express a ...

 


Aratana Therapeutics (PETX) Granted Conditional License for Canine Osteosarcoma Therapeutic - StreetInsider.com



Aratana Therapeutics (PETX) Granted Conditional License for Canine Osteosarcoma Therapeutic 
StreetInsider.com
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, today announced the United States Department of Agriculture (USDA) Center ...
Aratana nabs conditional US license for canine bone cancer candidate AT-014; shares ahead 4% premarket Seeking Alpha

all 2 news articles »